International Business Machines Corporation IBM ← Back to all reports

International Business Machines Corporation

IBM · Technology
B ★★★ Hold
Oct 24, 2026 · Score 74 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $253.56
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $232.00 ($224.00–$240.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $262.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative Expected Return means the Price Target is below the report-date Current Price. This can occur even with a Buy or Strong Buy recommendation because recommendations follow a fixed mapping from the overall investment score, which combines business assessment, valuation and risk. This is a limitation of our score-based framework: a favorable recommendation does not always imply an attractive entry price. Consider the Price Target, Buy Zone and valuation analysis together.
Methodology →
+3.3%

Type A - International Business Machines Corporation (IBM) 20261024 Stock Analysis

📅 IBM Key Upcoming Events

🏢 Step 1: IBM Company Overview & Business Model

Q1-A1. What is IBM?

Q1-A2. How Does IBM Make Money?

Q1-A3. IBM’s Revenue Segments & Core Income Sources

Q1-A4. Who Are IBM’s Competitors?

Q1-A5. IBM Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: IBM’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does IBM Have a Durable Economic Moat?

Q2-A2. Is IBM’s Growth Sustainable?

Q2-A3. How Does IBM Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is IBM Profitable? Financial Health Analysis

Q3-A2. How Profitable Is IBM? (Margins & ROIC)

Q3-A3. What Drives IBM’s Returns? (ROIC Breakdown)

Q3-A4. Are IBM’s Earnings High Quality?

Q3-A5. Is IBM’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: IBM Forensic Accounting & Dilution Review

Q4-A1. Does IBM Have Accounting Red Flags?

Q4-A2. Is IBM Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is IBM’s Cash Flow?

Q4-A4. Is IBM Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: IBM Management & Shareholder Alignment

Q5-A1. Can You Trust IBM’s Management? (Guidance Track Record)

Q5-A2. What Are IBM Insiders Doing?

Q5-A3. Is IBM’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: IBM Market Flow & Sentiment

Q6-A1. Analyst Consensus vs IBM Guidance

Q6-A2. What Is IBM’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: IBM Catalysts & Price Triggers

Q7-A1. What Could Move IBM Stock? (Top 3 Catalysts)

Q7-A2. IBM’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is IBM Fairly Valued? Valuation Analysis

Q8-A1. IBM’s Key Valuation Multiples

Q8-A2. IBM vs Peers: Valuation Comparison

Q8-A3. Is IBM Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into IBM? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From IBM? (Reverse DCF Alternative)

Q8-A5. IBM’s Hidden Asset & Stake Valuation

Q8-A6. Final Valuation Adjustment

Q8-A7. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of IBM? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to IBM?

Q9-A2. How Sensitive Is IBM to the Economy?

Q9-A3. IBM Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: IBM Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy IBM? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. IBM’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is IBM’s Acquisition Dependence Its Biggest Weakness Despite Strong Software Growth?

Q2: Can IBM’s 19.40x Forward P/E Be Justified by Its Software-Led Transformation?

Q3: Can IBM Sustain High-Single-Digit Software Growth as Consulting Revenue Stagnates?

Q4: Does IBM’s Confluent Acquisition Create a Competitive Advantage in Enterprise AI?

Q5: Is IBM’s Free Cash Flow Strong Enough to Support Its Dividend and Acquisition Strategy?

Q6: Can IBM Improve ROIC After Spending Billions on Software Acquisitions?

Q7: Can IBM’s Mainframe Franchise Remain Relevant as Enterprises Adopt Cloud-Native Infrastructure?

Q8: Will IBM’s Consulting Business Recover as Enterprise AI Moves Into Production?

Q9: Is IBM’s Dividend More Attractive Than Its Potential Capital Appreciation?

Q10: What Would Make IBM a Stronger Long-Term Investment Over the Next Three Years?

Rating History

Rating History shows the Rating assigned on each report date. Only the latest report is available to read. Scores are omitted from the timeline because reports from different periods may follow different rating scales.

  1. 2026-07-02 B
  2. 2026-07-26 B
  3. 2026-10 B